JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Development of medical devices for neuro-interventional procedures: special focus on aneurysm treatment.

Since the introduction of the Guglielmi detachable coil in 1990, the role of endovascular treatment for intracranial aneurysm has changed significantly. However, this endovascular modality has intrinsic technical limitations in wide-neck and large (11-25 mm) or giant (>25 mm) aneurysms. Long-term anatomic outcomes for these aneurysms include an approximate 25% recanalization rate. Since the aneurysm recanalization is related to morphologic, hemodynamic and biologic factors associated with aneurysm healing, improvement of these factors has elicited several technical modifications of the original technique. This review will describe new endovascular devices that have been manufactured to improve the technical limitations inherited by the Guglielmi detachable coil technique, as well as the historic background of endovascular treatment for cerebral aneurysms.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app